J Pediatr Intensive Care 2020; 09(02): 113-118
DOI: 10.1055/s-0039-1700981
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Effect of Potassium Infusions on Serum Levels in Children during Treatment of Diabetic Ketoacidosis

1   Division of Critical Care, Department of Pediatrics, Southern Illinois University School of Medicine, Springfield, Illinois, United States
,
2   Department of Pediatrics, University of Illinois College of Medicine at Peoria, Illinois, United States
,
Aayush Khanal
1   Division of Critical Care, Department of Pediatrics, Southern Illinois University School of Medicine, Springfield, Illinois, United States
,
Kimberly Powell
1   Division of Critical Care, Department of Pediatrics, Southern Illinois University School of Medicine, Springfield, Illinois, United States
,
Giovanna Caprirolo
1   Division of Critical Care, Department of Pediatrics, Southern Illinois University School of Medicine, Springfield, Illinois, United States
,
Ryan Majcina
1   Division of Critical Care, Department of Pediatrics, Southern Illinois University School of Medicine, Springfield, Illinois, United States
,
Randall S. Robbs
3   Center for Clinical Research, Southern Illinois University School of Medicine, Springfield, Illinois, United States
› Institutsangaben
Funding None.
Weitere Informationen

Publikationsverlauf

27. September 2019

27. November 2019

Publikationsdatum:
08. Januar 2020 (online)

Abstract

A retrospective study was done to determine the effect of potassium (K+) infusions on serum levels in children admitted to the pediatric intensive care unit (PICU) with diabetic ketoacidosis (DKA). Eighty-two percent of 92 cases studied received 40 mEq/L K+ infusion over the treatment period of median 13.0 (interquartile range [IQR]: 7–18) hours. The median K+ value at the end of this period was 3.9 (IQR: 3.4–4.2) mEq/L. There were 31 data points of low K+ values (<3.5 mEq/L) and 4 high values (>5.5 mEq/L) during this treatment period. The K+ infusions of 40 mEq/L may be sufficient to normalize serum K+ when treating DKA.

Note

This work was performed at St. John's Children's Hospital, Southern Illinois University School of Medicine in Springfield, Illinois. The pediatric department of Southern Illinois University provided logistical support.


 
  • References

  • 1 Wolfsdorf JI, Glaser N, Agus M. , et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes 2018; 19 (Suppl. 27) 155-177
  • 2 Liamis G, Liberopoulos E, Barkas F, Elisaf M. Diabetes mellitus and electrolyte disorders. World J Clin Cases 2014; 2 (10) 488-496
  • 3 Adrogué HJ, Lederer ED, Suki WN, Eknoyan G. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore) 1986; 65 (03) 163-172
  • 4 Nabarro JD, Spencer AG, Stowers JM. Metabolic studies in severe diabetic ketosis. Q J Med 1952; 21 (82) 225-248
  • 5 Atchley DW, Loeb RF, Richards Jr DW, Benedict EM, Driscoll ME. On Diabetic Acidosis: a detailed study of electrolyte balances following the withdrawal and reestablishment of insulin therapy. J Clin Invest 1933; 12 (02) 297-326
  • 6 Darrow DC, Pratt EL. Retention of water and electrolyte during recovery in a patient with diabetic acidosis. J Pediatr 1952; 41 (06) 688-696
  • 7 Danowski TS, Peters JH, Rathbun JC, Quashnock JM, Greenman L. Studies in diabetic acidosis and coma, with particular emphasis on the retention of administered potassium. J Clin Invest 1949; 28: 1-9
  • 8 Nguyen TQ, Maalouf NM, Sakhaee K, Moe OW. Comparison of insulin action on glucose versus potassium uptake in humans. Clin J Am Soc Nephrol 2011; 6 (07) 1533-1539
  • 9 Aronson PS, Giebisch G. Effects of pH on potassium: new explanations for old observations. J Am Soc Nephrol 2011; 22 (11) 1981-1989
  • 10 West ML, Magner PO, Richardson RM, Halperin ML. A renal mechanism limiting the degree of potassium loss in severely hyperglycemic patients. Am J Nephrol 1988; 8 (05) 373-378
  • 11 Tattersall RB. A paper which changed clinical practice (slowly). Jacob Holler on potassium deficiency in diabetic acidosis (1946). Diabet Med 1999; 16 (12) 978-984
  • 12 Carlotti AP, St George-Hyslop C, Bohn D, Halperin ML. Hypokalemia during treatment of diabetic ketoacidosis: clinical evidence for an aldosterone-like action of insulin. J Pediatr 2013; 163 (01) 207-12.e1
  • 13 Gennari FJ. Hypokalemia. N Engl J Med 1998; 339 (07) 451-458
  • 14 Ingram TC, Olsson JM. In brief: hypokalemia. Pediatr Rev 2008; 29 (09) e50-e51
  • 15 Kim GH, Han JS. Therapeutic approach to hypokalemia. Nephron 2002; 92 (Suppl. 01) 28-32
  • 16 Singhi S, Gautham KS, Lal A. Safety and efficacy of a concentrated potassium chloride solution infusion for rapid correction of hypokalemia. Indian Pediatr 1994; 31 (05) 565-569
  • 17 Rimmer JM, Horn JF, Gennari FJ. Hyperkalemia as a complication of drug therapy. Arch Intern Med 1987; 147 (05) 867-869